Effect of Dexmedetomidine on Sevoflurane in Young Children
Official title: Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
Run by Baylor College of Medicine · NCT03384563 · Data updated 2026-11-12
This study is testing how different doses of a medication called Dexmedetomidine can change the amount of anesthesia needed for young children during surgery.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 1 Month to 36 Months |
| Sex | All |
| Enrollment | 180 (estimated) |
| Sponsor | Baylor College of Medicine Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | February 18, 2018 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | September 22, 2025 |
| Trial ID | NCT03384563 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 1 month to 3 years who are scheduled for surgery.
✕Probably not a fit
Patients with significant comorbidities such as congenital heart disease, central nervous system disorders, or those with a history of difficult intubation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate how two different dosages of Dexmedetomidine (0.5mcg/kg and 1mcg/kg) influence the minimum alveolar concentration (MAC) of Sevoflurane in children aged 1 month to 3 years. The MAC is a critical measure of anesthetic potency, indicating the dose required to prevent movement in response to surgical stimuli. By assessing the effects of Dexmedetomidine on MAC, the study seeks to optimize anesthesia protocols for pediatric patients undergoing surgery. The research will involve children from three age groups: 1-6 months, 6-12 months, and 12-36 months.
Why it matters
Potential benefit: If successful, this study could lead to improved anesthesia management in young children, enhancing safety and efficacy during surgical procedures.
How similar studies have gone: Previous studies have shown that Dexmedetomidine can effectively reduce the MAC of inhalational anesthetics in adults, suggesting potential success in pediatric applications.
Who can join: the full rules
Show full inclusion / exclusion criteria
Exclusion Criteria: 1. Interstitial lung disease, chest wall disease, or bronchospastic disease with no flare-ups in the past 2 weeks of presentation 2. History of difficult intubation or ventilation 3. Airway malformation 4. Congenital heart disease 5. Cardiac arrhythmias 6. Central nervous system disease, including developmental delay, cerebral palsy, or seizure disorder 7. History of or family history of malignant hyperthermia 8. Electrolyte disorders 9. Gastrointestinal disease 10. Hepatic dysfunction 11. Renal dysfunction 12. Metabolic disease, such as diabetes 13. Obesity, defined as a body mass index greater than the 95% percentile for age 14. Preterm infant (less than 37 weeks gestational age) 15. Use of any medications (anticonvulsants, opioids, benzodiazepines, antibiotics, antihistamines drugs that induce hepatic enzymes) that may affect MAC. Inclusion Criteria All patients age 1 month- 3 years presenting for surgery.
Where it's running
-
Texas Children's Hospital
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Rahul Baijal, MD — Baylor College of Medicine
- Study coordinator: Margaret Owens-Stuberfield
- Email: owensstu@bcm.edu
- Phone: 832-824-5800
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Caudal Block for Distal Hypospadias Repair in Young Boys
This trial tests whether adding a caudal block to general anesthesia affects fistula formation after distal hypospadias repair in boys aged 6–60 months.
-
Intranasal dexmedetomidine versus oral midazolam for premedication in children having elective inguinal or urological surgery
This trial will test whether intranasal dexmedetomidine or oral midazolam works better to calm children aged 2–10 before elective inguinal or urological surgery.
-
Comparing Paedfusor and Eleveld propofol TCI versus sevoflurane for reducing wake-up agitation in children
This project will test whether two propofol target-controlled infusion methods (Paedfusor and Eleveld) or sevoflurane inhalation better prevent awakening agitation in children aged 3–10 having planned urogenital surgery.
-
Giving Children a Voice in Pediatric Anesthesia
This project tests whether asking children, parents, and clinicians about priorities can shape future pediatric anesthesia research in Switzerland.
-
Oral Premedication Choices to Help Kids Tolerate Venipuncture in Day-Case Surgery
This study tests whether giving oral midazolam alone or with ibuprofen or ketamine helps children ages 4–12 tolerate vein access better during ambulatory procedures.
-
Predicting difficult airways in children before surgery
This project will test whether simple preoperative airway checks can predict which children (0–12 years) will have a difficult airway during elective surgery under general anesthesia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.